ReviewBlood cancer journal2022
Resistance to targeted therapies: delving into FLT3 and IDH.
Sai Prasad Desikan et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
23 papers cite it
this papercites it
ReviewBlood cancer journal2022
Sai Prasad Desikan et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.